TrialBritish journal of cancer2024

Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study.

Baoqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.